← Back to directory

Antonio Giordano

Researcher Next ID · RN-019269

Researcher · Medicine

University of Siena

Siena, Spain

Not currently recruitingFunding unknown
Works count
1,310
Citation count
57,121
H-index
103
i10-index
737

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Cancer-related Molecular Pathways
Epigenetics and DNA Methylation
Ubiquitin and proteasome pathways
Cancer Cells and Metastasis
RNA modifications and cancer

Publications

  • Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications

    Current Issues in Molecular Biology · 2023 · 10.3390/cimb45080420

  • p53 signaling in cancer progression and therapy

    Cancer Cell International · 2021 · 10.1186/s12935-021-02396-8

  • Role of p53 in the Regulation of Cellular Senescence

    Biomolecules · 2020 · 10.3390/biom10030420

  • Curcumin and Cancer

    Nutrients · 2019 · https://doi.org/10.3390/nu11102376

  • Virtual Reality as a Distraction Intervention to Relieve Pain and Distress During Medical Procedures

    Clinical Journal of Pain · 2018 · 10.1097/ajp.0000000000000599

  • Brown adipose tissue whitening leads to brown adipocyte death and adipose tissue inflammation

    Journal of Lipid Research · 2018 · 10.1194/jlr.m079665

  • Virtual Reality in Health System: Beyond Entertainment. A Mini‐Review on the Efficacy of VR During Cancer Treatment

    Journal of Cellular Physiology · 2015 · 10.1002/jcp.25117

  • Cell cycle kinases as therapeutic targets for cancer

    Nature Reviews Drug Discovery · 2009 · https://doi.org/10.1038/nrd2907

  • Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials

    Journal of Clinical Oncology · 2007 · 10.1200/jco.2007.11.3787

  • From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells

    Journal of Cellular Physiology · 2007 · 10.1002/jcp.20959

  • RB and cell cycle progression

    Oncogene · 2006 · https://doi.org/10.1038/sj.onc.1209615

  • Smart materials as scaffolds for tissue engineering

    Journal of Cellular Physiology · 2005 · 10.1002/jcp.20270

  • Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer

    Endocrine Related Cancer · 2005 · 10.1677/erc.1.00857

  • Advantages and limitations of microarray technology in human cancer

    Oncogene · 2003 · 10.1038/sj.onc.1206865

  • From Cell–ECM interactions to tissue engineering

    Journal of Cellular Physiology · 2003 · 10.1002/jcp.10471

  • Cell Cycle and Apoptosis

    Neoplasia · 2000 · 10.1038/sj.neo.7900101

  • p300 and CBP: Partners for life and death

    Journal of Cellular Physiology · 1999 · 10.1002/(sici)1097-4652(199911)181:2<218::aid-jcp4>3.0.co;2-5

  • p300 is required for MyoD‐dependent cell cycle arrest and muscle‐specific gene transcription

    The EMBO Journal · 1997 · 10.1093/emboj/16.2.369

  • Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.

    PubMed · 1997

  • Simian virus-40 large-T antigen binds p53 in human mesotheliomas

    Nature Medicine · 1997 · 10.1038/nm0897-908

  • Recruitment of p300/CBP in p53-Dependent Signal Pathways

    Cell · 1997 · https://doi.org/10.1016/s0092-8674(00)80304-9

  • Human p300 Protein Is a Coactivator for the Transcription Factor MyoD

    Journal of Biological Chemistry · 1996 · 10.1074/jbc.271.15.9009

  • Cyclins, Cyclin-Dependent Kinases and Cdk Inhibitors: Implications in Cell Cycle Control and Cancer

    Critical Reviews in Eukaryotic Gene Expression · 1995 · 10.1615/critreveukargeneexpr.v5.i2.20

  • Formation and Activation of a Cyclin E-cdk2 Complex During the G 1 Phase of the Human Cell Cycle

    Science · 1992 · https://doi.org/10.1126/science.1388288

  • A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells

    Cell · 1989 · 10.1016/0092-8674(89)90949-5

Current projects

    No projects listed.